Pall India, Spinchrom Ink Indian Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Pall today announced an exclusive distribution deal covering India between Pall India and Spinchrom Life Sciences, a division of Spinco Biotech.

Spinchrom, which on focuses on the life sciences and consumables markets, will be the exclusive distributor in India of ForteBio's Blitz system for the label-free analysis of proteins with small sample volumes. ForteBio is a division of Pall Life Sciences and supplies label-free technology for the development of biotherapeutic and pharmaceutical products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.